List of Figures
Ischemic Stroke Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Ischemic Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 13
Proportion of Ischemic Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Ischemic Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 17
Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Ischemic Stroke Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Ischemic Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Ischemic Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Ischemic Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
GlobalData Methodology 504


List of Tables
Ischemic Stroke Therapeutics, Global, Clinical Trials by Region, 2017* 6
Ischemic Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13
Proportion of Ischemic Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Ischemic Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 17
Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Ischemic Stroke Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Ischemic Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Ischemic Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Ischemic Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28